This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Intercept Pharmaceuticals, Inc., Les Laboratoires Servier. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Klaus Seedorf: Innovator in TGR5 Modulators
Introduction
Klaus Seedorf is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of TGR5 modulators. With a total of 4 patents to his name, Seedorf's work is paving the way for innovative treatments for various diseases.
Latest Patents
Seedorf's latest patents focus on TGR5 modulators and their methods of use. The applications relate to compounds of formula A, which can include salts, solvates, esters, tautomers, amino acid conjugates, or metabolites. These compounds are designed to be useful in treating a range of diseases, including metabolic, inflammatory, autoimmune, cardiac, kidney, cancer, and gastrointestinal diseases.
Career Highlights
Klaus Seedorf is currently associated with Intercept Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His innovative approach to drug development has garnered attention in the pharmaceutical industry.
Collaborations
Seedorf has collaborated with notable colleagues, including Roberto Pellicciari and Antimo Gioiello. These partnerships have contributed to the success of his research and the advancement of TGR5 modulators.
Conclusion
Klaus Seedorf's work in the field of TGR5 modulators represents a significant advancement in the treatment of various diseases. His innovative contributions and collaborations continue to shape the future of pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile